GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer.
Saved in:
| Title: | GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer. |
|---|---|
| Authors: | Ye, Ling1 (AUTHOR), Zheng, Nannan1,2 (AUTHOR), Liu, Fangming3 (AUTHOR), Fu, Huirong1,4 (AUTHOR), Liu, Yifei5 (AUTHOR), Yang, Ying6 (AUTHOR), Qi, Ruixue6 (AUTHOR), Wu, Duojiao6,7 (AUTHOR), Shi, Lin1 (AUTHOR) linshi0124@126.com, Song, Dongli1,3,7 (AUTHOR) songdongli37@126.com |
| Source: | Clinical & Translational Discovery. Feb2026, Vol. 6 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
